PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Yesterday, in the presence of numerous guests, the new project partners NEMERA and NOVO NORDISK laid the foundation stone for a new manufacturing Hall

The new building will be mostly dedicated to the production of components for Novo Nordisk’s pen needles. Marc  HÄMEL,  NEMERA’s  CEO  and  Morten  Keller  CASPERS...
Continue Reading →
News

Aptar Pharma Co-Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril, Portugal

Crystal Lake, Illinois, March 21, 2019 Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its co- organization and diamond sponsor...
Continue Reading →
News

PCI Announces Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity and boost powder han...
Continue Reading →
News

PCI Pharma Services Appoints New Chief Financial Officer, SVP, Serge Dupuis

Philadelphia, PA – 22 March, 2019. Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to welcome Serge Dupuis as Sen...
Continue Reading →
News

BioAgilytix Europe appoints new Scientific Officer

BioAgilytix, a leading global bioanalytical testing laboratory specializing in the bioanalysis of biopharmaceuticals, is pleased to announce the appointment of ...
Continue Reading →
News

Sage’s postpartum depression drug is approved. Now comes the hard part

The Food and Drug Administration on Tuesday issued its first-ever approval of a postpartum depression therapy, offering a new treatment option for the roughly one...
Continue Reading →
News

Biohaven pays $105M for GW Pharma’s priority review voucher

Biohaven Pharmaceuticals will pay $105 million to GW Pharmaceuticals for a priority review voucher, hoping to speed up the timeline to commercialization for its e...
Continue Reading →
News

Mylan and Hospira both recall injected drugs after particulate discovered in vials

Mylan is recalling two lots of levoleucovorin and Hospira is recalling three lots of sodium bicarbonate injection after particles were discovered in vials. Mylan...
Continue Reading →
News

Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges

The FDA Tuesday approved Sage's Zulresso after a three-month REMS-related delay. Sage Therapeutics has the first-ever approval for a prescription drug for postpart...
Continue Reading →
News

Diabetes drug effective against heart failure in wide spectrum of patients

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026